Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS
(2003; 92 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentGlossary
View the document1. Introduction
View the document2. Pricing
View the document3. Access to quality HIV/AIDS medicines and diagnostics
View the document4. Sources & prices of medicines
View the document5. Variation in price between surveys
View the documentAnnex 1A. Registration status of products included in the sources and prices survey
View the documentAnnex 1B. Index of manufacturers
View the documentAnnex 1C. Geographical distribution of par ticipating manufacturers
View the documentAnnex 2. WHO Bulk Procurement Scheme 2003
View the documentAnnex 3A. Summary of main characteristics of methods forCD4/CD8 lymphocyte determination
View the documentAnnex 3B. Summary of main characteristics of viral load technologies
View the documentAnnex 4. Further reading, references, and contacts
View the documentAnnex 5. Feedback and enquiry form
Close this folderAnnex 6. Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries
View the documentGeneral background and objectives
View the documentMethodology
View the documentLimitations of the current system
View the documentThe challenge of paediatric formulations
View the documentResearch and development for HIV/AIDS
View the documentThe Effects of Generic Competition
View the documentGuide to reading and using tables
Open this folder and view contentsTables
Close this folderAnnexes
View the documentAnnex 1: Least Developed Countries (LDCs)
View the documentAnnex 2: Human Development Index (HDI)
View the documentAnnex 3: Sub-Saharan countries
View the documentAnnex 4: World Bank low-income countries
View the documentAnnex 5: Company contacts
View the documentGlossary12
View the documentReferences
 

Annex 5: Company contacts

Abbott:

Rob Dintruff
Email: rob.dintruff@abbott.com

AXIOS International manages the application process and serves as the central contact:

The Programme Manager
Access to HIV Care Programme
AXIOS International
P.O. Box 6924
Kampala, Uganda.
Tel: +256 75 693 756
Fax: +256 41 543 021
Email: AccesstoHIVCare@axiosint.com
Website: www.accesstohivcare.org

Aurobindo Pharma Ltd:

Venkateshan
Regional Manager (Latin America & Europe)
Tel: +91 40 373 7332 (Direct)
Or +91 98480 257 64 (Mobile)
Fax: +91 40 374 10 80
Email: venky@aurobindo.com

Bristol-Myers Squibb Co:

Robert D. Lefebvre
Senior Director, Project Access
Bristol-Myers Squibb
P.O. Box 4000
Princeton, NJ 08543-4000, USA
Tel: +1.609.252.4592
Fax: +1.609.252.4819
E-mail: robert.lefebvre@bms.com

West Africa: information can be obtained from Ms Marie-Astrid
Mercier, BMS Access Coordinator in BMS Paris office (marieastrid.mercier@bms.com)

East Africa: information can be obtained from BMS main distributor in East Africa - M. Mukesh Mehta at Phillips Pharmaceuticals in Nairobi

(ppl@phillipspharma.com).

Southern Africa: information can be obtained from Ms Tamany Geldenhuys in BMS offices in Johannesburg

(tamany.geldenhuys@bms.com).

Boehringer Ingelheim:

Laurence Phillips (for preferential prices)
CD Marketing Prescription Medicines
HIV-Specialists/Virologists
Phone: + 49 6132 77-2081
Fax: +49 6132 77-3829
Email: phillips@ing.boehringeringelheim.com

Hélène Clary (for donations)
Marketing Prescription Medicines
CG HIV-Specialists/Virologists
Tel: + 49 6132 77-34 36
Fax: + 49 6132 77-38 29
Email: claryh@ing.boehringeringelheim.com

Cipla Ltd:

Sanjeev Gupte, General Manager-Exports
Cipla Limited and Shailesh Pednekar
Executive-Exports, Cipla Limited
Tel: +91 22 3021397 (Direct) 3095521 3092891
Fax: +91 223070013/3070393/3070385
Email: exports@cipla.com and ciplaexp@cipla.com

Combinopharm:

Silvia Gil
Managing Director
Combinopharm
Tel: + 34 93 48 08 833
Fax: + 34 93 48 08 832
Email: export@combino-pharm.es

Gilead

Programme Access (primary contact)
Gilead Access Program
Axios International
Plot 1 Pilkington Road
6th Floor Workers House Building
P.O. Box 6924
Kampala
Uganda
Tel: +256-41-340806/7
Fax: +256-41-340642
Email: GileadAccess@axiosint.com

Company contact
Joe Steele
Senior Director, Commercial
Development
Gilead Sciences
333 Lakeside Drive
Foster City, California 94404
1-650-522-5740

GlaxoSmithKline:

Jon Pender
Di rector External Relations
Global Access Issues
Tel: + 44 (0) 20 8047 5489
Fax: + 44 (0) 208 047 6957
Email: jon.d.pender@gsk.com

GPO:

Sukhum Virattipong
Export Manager
Tel: + 662 248 1482, + 662 203 8808
Fax: + 662 248 1488
Email: sukhum@health.moph.go.th

Hetero:

Dharmesh Shah
Director International Business
Development, Hetero International
408 Sharda Chambers, 15 New
Marine Lines, Mumbai 400 020, India
Tel: +91 22 563 318 68
Tel (direct): +91 22 563 318 61
Fax: +91 22 220 660 99
Email: hint@bom5.vsnl.net.in

Merck & Co. Inc:

Dr Jeffrey L. Sturchio
Vice President, External Affairs
Human Health Europe, Middle East & Africa
Merck & Co., Inc/WS2A-55
One Merck Drive
Whitehouse Station
NJ 08889-0100 USA
Tel: +1 908 423 39 81
Fax: +1 908 735 1704
Email: jeffrey_sturchio@merck.com

Ranbaxy:

Sandeep Juneja
Ranbaxy Laboratories Limited
Tel: + 91 11 600 2120 (Direct)
or + 91 11 645 2666-72
Fax: + 91 11 600 2121
Email: sandeep.juneja@ranbaxy.com

Roche:

For information regarding quotations and deliveries to customers contact:
Hanspeter Walchli
Logistics Sales International
Customers
Dept. PTBS-IM
4070 Basel/Switzerland
Tel: +41 61 688 1060
Fax: +41 61 687 1815
Email: hanspeter.waelchli@roche.com

to previous section to next section
 

Last updated: May 3, 2013